These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5002750)

  • 41. Effect of sulfonylurea treatment and fasting on the levels of plasma amino acids in the rat.
    Palou A; Alemany M; Herrera E
    Horm Metab Res; 1978 Nov; 10(6):482-9. PubMed ID: 105980
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of glipizide on the release of insulin in the perfused rat pancreas in vitro.
    Tasaka Y; Sekine M; Sugimoto C; Ogawara H; Shizume K
    Endocrinol Jpn; 1974 Jun; 21(3):279-81. PubMed ID: 4426313
    [No Abstract]   [Full Text] [Related]  

  • 43. Sulfonylureas stimulate renin secretion from the perfused kidney of the rat.
    Ochi H; Ikeda T
    Nephron; 1999 Jan; 81(1):67-71. PubMed ID: 9884422
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glycogen phosphorylase activities in sulfonylureas treated rats.
    Remesar X; Herrera E; Alemany M
    Horm Metab Res; 1978 Jul; 10(4):355. PubMed ID: 98423
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of glibenclamide on hepatic fructose metabolism.
    Poser W; Schönborn J; Panten U; von Kriegstein E; Hasselblatt A
    Horm Metab Res; 1971 Nov; 3(6):447-8. PubMed ID: 5002239
    [No Abstract]   [Full Text] [Related]  

  • 46. [Comparison of the beta-cytotropic effect of glymidine sodium (glycodiazine), glucagon, and isopropylnoradrenaline in rats].
    Losert W; Loge O; Jahn P
    Arzneimittelforschung; 1973 Sep; 23(9):1251-60. PubMed ID: 4149442
    [No Abstract]   [Full Text] [Related]  

  • 47. The inhibition in vitro of hepatic protein biosynthesis by various oral hypoglycemic agents--site of action.
    DeChatelet LR; McDonald HJ
    Biochem Pharmacol; 1969 Mar; 18(3):595-602. PubMed ID: 5772590
    [No Abstract]   [Full Text] [Related]  

  • 48. Insulinotropic action of a new sulfonylurea: gliclazide.
    Malaisse WJ; Leclercq-Meyer V
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):310-4. PubMed ID: 4626523
    [No Abstract]   [Full Text] [Related]  

  • 49. [Recent findings in the use of 1st and 2nd generation hypoglycemic sulfonamides].
    Schöffling K; Haupt E; Köberich W; Beyer J
    Klin Wochenschr; 1973 Jan; 51(2):68-77. PubMed ID: 4631325
    [No Abstract]   [Full Text] [Related]  

  • 50. Sulfonylurea stimulates liver fructose-2,6-bisphosphate formation in proportion to its hypoglycemic action.
    Hatao K; Kaku K; Matsuda M; Tsuchiya M; Kaneko T
    Diabetes Res Clin Pract; 1985 Mar; 1(1):49-53. PubMed ID: 3939113
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extrapancreatic effects of sulfonylurea drugs.
    Kaku K; Inoue Y; Kaneko T
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S105-8. PubMed ID: 8529502
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of hypoglycemic agents on liver regeneration.
    Gershbein LL
    Biochem Pharmacol; 1967 Jun; 16(6):1117-20. PubMed ID: 6040393
    [No Abstract]   [Full Text] [Related]  

  • 53. Drug interactions with oral sulphonylurea hypoglycaemic drugs.
    Hansen JM; Christensen LK
    Drugs; 1977 Jan; 13(1):24-34. PubMed ID: 401727
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of catecholamine release by tolbutamide and other sulfonylureas.
    Hsu CY; Brooker G; Peach MJ; Westfall TC
    Science; 1975 Mar; 187(4181):1086-7. PubMed ID: 1114337
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolic effects of hypoglycemic sulfonylureas. II. In vitro effect of sulfonylureas on cell-free protein synthesis and energy metabolism in rat tissues.
    De Beer L; De Schepper PJ
    Biochem Pharmacol; 1967 Dec; 16(12):2355-67. PubMed ID: 6075396
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of in vivo administration of various oral hypoglycemic agents on hepatic protein synthesis.
    DeChatelet LR; McDonald HJ
    Proc Soc Exp Biol Med; 1968 Feb; 127(2):415-8. PubMed ID: 5645028
    [No Abstract]   [Full Text] [Related]  

  • 57. Tormentic acid, a new hypoglycemic agent from Poterium ancistroides.
    Villar A; Payá M; Hortigüela MD; Cortes D
    Planta Med; 1986 Feb; (1):43-5. PubMed ID: 3085116
    [No Abstract]   [Full Text] [Related]  

  • 58. Hypoglycemic activities of MTP-3631, a novel thiopyranopyrimidine derivative.
    Ogawa H; Kunoh Y; Sugiura T; Nagasaka M
    Life Sci; 1992; 50(5):375-81. PubMed ID: 1732707
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of tolbutamide, mesoxalate and phenformin in vitro on the liberation of nitrogen by rat liver slices.
    GOTO Y; LUKENS FD
    Diabetes; 1961; 10():52-7. PubMed ID: 13707419
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical and experimental studies of insulin secretion following tolbutamide and metahexamide administration.
    PFEIFFER EF; PFEIFFER M; DITSCHUNEIT H; AHN CS
    Ann N Y Acad Sci; 1959 Sep; 82():479-95. PubMed ID: 14432532
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.